Open access
Five-year results of short-course brentuximab vedotin combined with chemotherapy and radiation in early stage, unfavorable Hodgkin lymphoma.
Robert N. Stuver
Esther Drill
L. Michaud
C. Casulo
R. Advani
E. Budde
P. Barr
Connie Lee Batlevi
P. Caron
L. Constine
P. Drullinsky
S. Dandapani
Jonathan W. Friedberg
C. Grieve
P. Hamlin
R. Hoppe
S. Horwitz
N. Khan
A. Joseph
M. Matasar
A. Noy
M. Palomba
H. Schöder
David J. Sraus
Shreya Vemuri
J. Yahalom
Joanna C. Yang
A. Zelenetz
Craig H. Moskowitz
Anita Kumar
A. Moskowitz
Medicine
Abstract
Not available.